Ivy Capital
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Ivy Capital is a premier venture capital and growth equity firm that finances early- or growth-stage companies.
Investor Profile
Ivy Capital has backed more than 11 startups, with 2 new investments in the last 12 months alone. The firm has led 1 rounds, about 9% of its total and boasts 12 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Medical, Information Technology, Biotechnology.
- Led 1 rounds in the past year.
Stage Focus
- Series C (36%)
- Series Unknown (27%)
- Series A (18%)
- Series B (9%)
- Series E (9%)
Country Focus
- China (73%)
- United States (27%)
Industry Focus
- Medical
- Information Technology
- Biotechnology
- Health Care
- Software
- Medical Device
- Biopharma
- Clinical Trials
- Cloud Computing
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Ivy Capital frequently co-invest with?
What are some of recent deals done by Ivy Capital?
Find More Investors Like Ivy Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
